PARICALCITOL and DEATH

Overview

DEATH is the #1 most commonly reported adverse reaction for PARICALCITOL, manufactured by AbbVie Inc.. There are 3,570 FDA adverse event reports linking PARICALCITOL to DEATH. This represents approximately 18.5% of all 19,271 adverse event reports for this drug.

Patients taking PARICALCITOL who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DEATH is a frequently reported adverse event for PARICALCITOL, accounting for a significant proportion of all reports.

Other Side Effects of PARICALCITOL

In addition to death, the following adverse reactions have been reported for PARICALCITOL:

• CARDIAC DISORDER — 621 reports
• MYOCARDIAL INFARCTION — 584 reports
• SEPSIS — 483 reports
• CARDIO RESPIRATORY ARREST — 476 reports
• DYSPNOEA — 393 reports
• CARDIAC FAILURE — 349 reports
• RENAL FAILURE — 308 reports
• PNEUMONIA — 301 reports
• NAUSEA — 299 reports
• CEREBROVASCULAR ACCIDENT — 285 reports

Other Drugs Associated with DEATH

The following drugs have also been linked to death in FDA adverse event reports:

Does PARICALCITOL cause DEATH?

DEATH has been reported as an adverse event in 3,570 FDA reports for PARICALCITOL. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DEATH with PARICALCITOL?

DEATH accounts for approximately 18.5% of all adverse event reports for PARICALCITOL, making it one of the most commonly reported side effect.

What should I do if I experience DEATH while taking PARICALCITOL?

If you experience death while taking PARICALCITOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages